Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure
Filippos Triposkiadis, Αndrew Xanthopoulos, John Skoularigis, Randall C. Starling
Topics & Concepts
SildenafilMedicineRiociguatcGMP-specific phosphodiesterase type 5Cyclic guanosine monophosphateVasodilationHeart failurePulmonary hypertensionCardiologyNitric oxideInternal medicineTadalafilPulmonary arteryPharmacologyChronic thromboembolic pulmonary hypertensionPulmonary Hypertension Research and TreatmentsNitric Oxide and Endothelin EffectsHeart Failure Treatment and Management